1. Platelet-rich plasma (BTP) and coagulation factor as a drug, where the drug is a non-coagulated mixture. 2. The use of BOTP and coagulation factor for the manufacture of a medicament for enriching a stem cell pool, preferably a pool of precursor endothelial cells and / or mesenchymal stem cells (MSCs) of a mammalian subject. 3. The use of BTP and coagulation factor for the manufacture of a medicament for the treatment and / or prophylaxis of a disease selected from the group consisting of cardiovascular disease, neurological disease and autoimmune disease. 4. The use according to claim 3, wherein the cardiovascular disease is selected from the group consisting of cardiomyopathy, (congenital) heart disease, coronary artery disease, ischemia, diastolic dysfunction, atherosclerosis, myocarditis, endocarditis and / or myocardial infarction. 5. The use according to claim 3, wherein the neurological disease is selected from the group consisting of Parkinson's disease, Alzheimer's disease, Huntington's disease, Tay-Sachs disease, spinal cord injury, stroke, stroke and amyotrophic lateral sclerosis (ALS) .6. The use of claim 3, wherein the autoimmune disease is selected from the group consisting of aplastic anemia, multiple sclerosis, rheumatoid arthritis, Sjogren's syndrome, type 1 diabetes mellitus, Graves' disease and / or lupus erythematosus. The use of BTP and coagulation factor for the manufacture of a medicament for the treatment and / or prevention of degenerative bone disease, preferably selected from the group consisting of bone atrophs1. Богатая тромбоцитами плазма (БоТП) и фактор коагуляции в качестве лекарственного средства, где лекарственное средство представляет собой некоагулированную смесь.2. Применение БоТП и фактора коагуляции для изготовления лекарственного средства для обогащения пула стволовых клеток, предпочтительно пула эндотелиальных клеток предшественниц и/или мезенхимальных стволовых клеток (МСК) субъекта млекопитающего.3. Применение БоТП и фак
